Insulin-like growth factor binding protein-4 expression is dependent on the carbohydrate in the media in HT-29 cells

Growth Hormone and IGF Research

Volumn 12, Issue 3, 2002, Pages 184-192

  Corkins, Mark R ^a,c   McQuade, Jennifer ^a   Schaffer, Beverly S ^b   MacDonald, Richard G ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Differentiation; Entrocyte; HT 29; IGF II; Insulin like growth factor binding protein 4; Retinoic acid

Indexed keywords

CARBOHYDRATE; GALACTOSE; GLUCOSE; RETINOIC ACID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 4;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN HT29; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY;

EID: 0036592169     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(02)00041-2     Document Type: Article

References (42)

1. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993; 55: 131-153.
2. Laburthe M, Rouyer-Fessard C, Gammeltoft S. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am J Physiol 1988; 254: G457-G462.
3. Park JHY, Vanderhoof JA, Blackwood D, MacDonald RG. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line. Endocrinology 1990; 126: 2998-3005.
4. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. Synthesis and characterization of insulin-like growth factor binding protein (IGFBP)-7. J Biol Chem 1996; 271: 30322-30325.
5. Corkins MR, Vanderhoof JA, Slentz DH, MacDonald RG, Park JHY. Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct. Biochem Biophys Res Commun 1995; 211: 707-713.
6. Park JHY, Corkins MR, Vanderhoof JA, Caruso NM, Hrbek MJ, Schaffer BS, Slentz DH, McCusker RH, MacDonald RG. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation. J Cell Physiol 1996; 166: 396-406.
7. Singh P, Dai B, Yallampalli C, Xu Z. Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. Am J Physiol 1994; 267: G608-G617.
8. Dai B, Widen SG, Mifflin R, Singh P. Cloning of the functional promoter for human insulin-like growth factor binding protein-4 gene: endogenous regulation. Endocrinology 1997; 138: 332-343.
9. Cianfarani S, Germani D, Rossi P, Spagnoli A, Mercanti D. Do insulin-like growth factor binding proteins (IGFBPs) modulate the IGF-I growth promoting and differentiating effects in human neuroblastoma cells?. Eur J Endocrinol 1996; 135: 716-723.
10. Bacon KD, Rutten MJ, Graham DL, Engstrom J, Sheppard BC, Crass RA, Deveney KE, Trunkey DD, Wilson EM, Hwa. V, Oh Y, Rosenfeld RG, Deveney CW. Retinoic acid induces differentiation and the expression of insulin-like binding protein-7 (IGFBP-7) in human gastric cancer cells. Gastroenterology 1998; 114: A865-A865.
11. Ewton DZ, Coolican SA, Mohan S, Chernausek SD, Florini JR. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J Cell Physiol 1998; 177: 47-57.
12. Rosenthal SM, Cheng Z-Q. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA 1995; 92: 10307-10311.
13. Damon SE, Haugk KL, Birnbaum RS, Quinn LS. Retrovirally mediated overexpression of insulin-like growth factor binding protein-4: evidence that insulin-like growth factor is required for skeletal muscle differentiation. J Cell Physiol 1998; 175: 109-120.
14. Ross SA, McCaffery PJ, Drager UC, De Luca LM. Retinoids in embryonal development. Physiol Rev 2000; 80: 1021-1054.
15. Zhou Y, Mohan S, Linkhart TA, Baylink DJ, Strong DD. Retinoic acid regulates insulin-like growth factor binding protein expression in human osteoblast cells. Endocrinology 1996; 137: 975-983.
16. Bardi G, Bottazzi C, Demori I, Palmero S. Thyroid hormone and retinoic acid induce the synthesis of insulin-like growth factor binding protein-4 in prepubertal pig sertoli cells. Eur J Endocrinol 1999; 141: 637-643.
17. Adamo ML, Clemmons DR, Lanau F, Chen JC, Clemmons DR, Roberts CTJ, LeRoith D, Fontana JA. Insulin-like growth factor-I (IGF- I) and retinoic acid modulation of IGF binding proteins (IGFBPs): IGFBP-2, -3 and -4 expression and protein secretion in a breast cancer cell line. Endocrinology 1992; 131: 1858-1866.
18. Conover C, Kiefer MC, Zapf J. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed fibroblasts. J Clin Invest 1993; 91: 1129-1137.
19. Kamyar A, Pirola CJ, Wang HM, Sharifi B, Mohan S, Forrester JS, Fagin JA. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ Res 1994; 74: 576-585.
20. Kuemmerle JF, Teng B. Regulation of IGFBP-4 levels in human intestinal muscle by an IGF-I activated, confluence-dependent protease. Am J Physiol 2000; 279: G975-G982.
21. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL, Rousset M. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 1985; 122: 21-29.
22. Mack DR, Hollingsworth MA. Alteration in expression of MUC2 and MUC3 mRNA levels in HT-29 cells. Biochem Biophys Res Commun 1994; 199: 1012-1018.
23. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138-143.
24. McCusker RH, Champion DR, Clemmons DR. The ontogeny and regulation of a 31,000 M, insulin-like growth factor/somatomedin (IGF) binding protein in fetal porcine plasma and sera. Endocrinology 1988; 122: 3071-3079.
25. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294--5299.
26. Shimasaki S, Uchiyama F, Shimonaka M, Ling N. Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol Endocrinol 1990; 4: 1451-1458.
27. Bowsher RR, Lee WH, Apathy JM, O'Brien PJ, Ferguson AL, Henry DP. Measurement of insulin-like growth factor-II in physiological fluids. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology 1991; 128: 805-814.
28. Culouscou JM, Shoyab M. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res 1991; 51: 2813-2819.
29. Hoeflich A, Yang Y, Huber S, Rascher W, Koepf G, Blum WF, Heinz-Erian P, Kolb HJ, Kiess W. Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cells. Am J Physiol 1996; 271: E922-E931.
30. Sanderson IR, Ezzell RM, Kedinger M, Erlanger M, Xu ZX, Pringault E, Leon-Robine S, Louvard D, Walker WA. Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix. Proc Natl Acad Sci USA 1996; 93: 7717--7722.
31. Schroy PC, Rustgi AK, Ikonomu E, Liu XP, Polito J, Andry C, O'Keane JC. Growth and intestinal differentiation are independently regulated in HT-29 colon cancer cells. J Cell Physiol 1994; 16: 111-123.
32. Singh P, Dai B, Dhruva B, Widen SG. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I. Cancer Res 1994; 54: 6563-6570.
33. Goossens K, Esquenet M, Swinnen JV, Manin M, Rombauts W, Verhoeven G. Androgens decrease and retinoids increase the expression of insulin-like growth factor binding protein-3 in LNcaP prostatic adenocarcinoma cells. Mol Cell Endocrinol 1999; 155: 9-18.
34. Cohick WS, Turner JD. Regulation of IGF binding protein synthesis by a bovine mammary epithelial cell line. J Endocrinol 1998; 157: 327-336.
35. Gabbitas B, Canalis E. Retinoic acid stimulates the transcription of insulin-like growth factor binding protein-6 in skeletal cells. J Cell Physiol 1996; 169: 15-22.
36. Chambery D, De Galle B, Ehrenborg E, Babajko S. Multi hormonal regulation of IGFBP-6 expression in human neuroblastoma cells. Growth Horm IGF Res 2000; 10: 349-359.
37. Babajko S, Binoux M. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 1996; 134: 474-480.
38. Gabbitas B, Canalis E. Retinoic acid regulates the expression of insulin-like growth factors I and II in osteoblasts. J Cell Physiol 1997; 172: 253-264.
39. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 1994; 16: 277-284.
40. Zarrilli R, Romano M, Pignata S, Casola S, Bruni CB, Acquaviva AM. Constitutive insulin-like growth factor-II expression interferes with the enterocyte-like differentiation of CaCo-2 cells. J Biol Chem 1996; 271: 8108-8114.
41. Durham SK, Riggs BL, Harris SA, Conover C. Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells. Endocrinology 1995; 136: 1374-1380.
42. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR, Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). J Biol Chem 1995; 270: 11377-11382.